retatrutide triple agonist obesity 🚨 Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ Retatrutide Severe Obesity Trial Shows

11 Micronutrient Synthesis: Supports folate (vitamin B9) production and contributes to vitamin B12 synthesis in vitro

EFSA Panel on Nutrition Novel Foods and Food Allergens

10.1038/onc.2012.641 57

Expert discovery is due March 27, with summary judgment motions due April 16 timing that allows plaintiffs to incorporate the warning letter into their filings

Mediating foam cell formation: CRP facilitates foam cell formation by enhancing LDL uptake in macrophages and influencing the production of reactive oxygen species

Results The triagonist promoted glucose-stimulated insulin secretion (GSIS) to a greater degree than co-administration of conventional mono-agonists in WT mouse islets